MENU
LXEO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Lexeo Therapeutics (LXEO) Ownership - Who owns Lexeo Therapeutics?

Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated... Show more

Profile

Industry
N/A
Address
345 Park Avenue South
Phone
+1 212 547-9879
Employees
58
Web
https://www.lexeotx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
563.46M
P/E Ratio
N/A
Total Cash
122.76M
Projected Growth
N/A
Total Debt
8.46M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
1.68
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

LXEO
Capitalization
563M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
123M
Total Cash/Share
1.68
Total Debt
8.46M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
121M
P/B Ratio
4.66
Cash Flow
N/A
Earnings
-2.5
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
5K
Current Ratio
7.40
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-102.69M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-66.08
Shares Held By Institutions
411M
Shares Outstanding - Current
73M
Total Liabilities
23M
Total Volume MTD
N/A
Value
-1
Gain YTD
-22.256
View a ticker or compare two or three
LXEO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. LXEO showed earnings on November 05, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
345 Park Avenue South
Phone
+1 212 547-9879
Employees
58
Web
https://www.lexeotx.com